Nanoviricides Inc (NNVC)
1.175
+0.04
(+3.98%)
USD |
NYAM |
Mar 28, 16:00
1.175
0.00 (0.00%)
After-Hours: 18:56
Nanoviricides Total Liabilities (Quarterly): 0.9511M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.9511M |
September 30, 2023 | 2.448M |
June 30, 2023 | 2.034M |
March 31, 2023 | 0.3487M |
December 31, 2022 | 0.4646M |
September 30, 2022 | 0.5184M |
June 30, 2022 | 0.4128M |
March 31, 2022 | 0.3867M |
December 31, 2021 | 0.3443M |
September 30, 2021 | 0.8695M |
June 30, 2021 | 0.3511M |
March 31, 2021 | 0.8713M |
December 31, 2020 | 0.3393M |
September 30, 2020 | 1.866M |
June 30, 2020 | 2.156M |
March 31, 2020 | 2.213M |
December 31, 2019 | 3.896M |
September 30, 2019 | 2.656M |
June 30, 2019 | 2.848M |
March 31, 2019 | 2.677M |
December 31, 2018 | 1.164M |
September 30, 2018 | 1.392M |
June 30, 2018 | 0.8819M |
March 31, 2018 | 3.194M |
December 31, 2017 | 7.808M |
Date | Value |
---|---|
September 30, 2017 | 6.747M |
June 30, 2017 | 6.681M |
March 31, 2017 | 6.174M |
December 31, 2016 | 12.22M |
September 30, 2016 | 14.00M |
June 30, 2016 | 13.59M |
March 31, 2016 | 14.34M |
December 31, 2015 | 12.46M |
September 30, 2015 | 11.59M |
June 30, 2015 | 12.40M |
March 31, 2015 | 13.74M |
December 31, 2014 | 17.10M |
September 30, 2014 | 12.19M |
June 30, 2014 | 20.49M |
March 31, 2014 | 8.920M |
December 31, 2013 | 12.68M |
September 30, 2013 | 13.36M |
June 30, 2013 | 8.398M |
March 31, 2013 | 7.753M |
December 31, 2012 | 1.397M |
September 30, 2012 | 1.557M |
June 30, 2012 | 1.780M |
March 31, 2012 | 0.8041M |
December 31, 2011 | 1.173M |
September 30, 2011 | 0.9912M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3393M
Minimum
Dec 2020
3.896M
Maximum
Dec 2019
1.433M
Average
0.9112M
Median
Total Liabilities (Quarterly) Benchmarks
Gilead Sciences Inc | 39.38B |
NovaBay Pharmaceuticals Inc | 5.815M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 17.66M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.40M |
Shareholders Equity (Quarterly) | 12.45M |